Home > Boards > US OTC > Medical - Healthcare > Guided Therapeutics Inc. (GTHP)

CFDA approval by July 2019 is impossible since

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
GetSeriousOK Member Profile
Member Level 
Followed By 20
Posts 2,905
Boards Moderated 0
Alias Born 09/06/14
160x600 placeholder
GetSeriousOK Member Level  Thursday, 04/18/19 04:13:22 PM
Re: Tmorgz post# 12887
Post # of 13167 
CFDA approval by July 2019 is impossible since Shandong hasn't even submitted the application yet.

But since Guided has nothing else on their plate, I'm quite sure they will re-negotiate with Shandong. Guided already overlooked the way Shandong was a year late on making the second part of that $1 million payment.

I can't see Gene giving the license back to Shenghuo because Shenghuo isn't going to fare any better in getting CFDA aproval.

I sure wish Gene or SOMEBODY would reveal what Shandong is planning to use in their CFDA application to prove efficacy (or to prove safety for that matter).

What has Shandong accomplished? They got $1 million in stock for their $1 million payment so they haven't paid GTHP anything yet, really. It's made for some shiny press releases but nothing else, so far, that we can prove.





Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist